BHVN Stock Analysis: Buy, Sell, or Hold?
BHVN - Biohaven Ltd.
$14.78
-0.72 (-4.65%)
βΌ
5d:
+21.75%
30d:
+55.91%
90d:
+69.11%
WAIT
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Smart Money Distribution
None View Scanner →
Strength: 7.8/10
Get Alerted When BHVN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR BETTER ENTRY: BHVN is 15.0% above its trading range ($12.85). While momentum could continue, risk/reward favors waiting for a pullback.
βΈοΈ WAIT FOR BETTER ENTRY: BHVN is 15.0% above its trading range ($12.85). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: BHVN is currently trading at $14.78, which is considered extended relative to its 30-day fair value range of $9.32 to $12.85.
Technical Outlook: Technically, BHVN is in a downtrend. Immediate support is located at $10.68, while resistance sits at $15.80. Short-term momentum is weak, with the stock down 4.6% recently.
Market Sentiment: BHVN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $21.71 (+46.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BHVN is in a downtrend. Immediate support is located at $10.68, while resistance sits at $15.80. Short-term momentum is weak, with the stock down 4.6% recently.
Market Sentiment: BHVN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $21.71 (+46.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$9.32 -
$12.85
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
47.4%
Protect Your Profits
BHVN is technically overbought (RSI 73). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+15.0% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.6%)
- BULLISH: Trading 46.9% below Wall St target ($21.71)
- WARNING: Recommendation downgraded due to 15.0% overvaluation
Trading Range Analysis
30-Day Trading Range
$9.32 -
$12.85
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$10.68
Resistance Level
$15.80
Current Trend
Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.57
Wall Street Target
$21.71
(+46.9%)
Share & Embed Analysis
Last updated: June 23, 2026 6:07 PM ET
Data refreshes hourly during market hours. Next update: 7:07 PM
Data refreshes hourly during market hours. Next update: 7:07 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BHVN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 54 HOLD |
|
NRIX
Nurix TherapeuticsΒ Inc |
STRONG BUY
18 analysts |
$31 | 62 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 55 HOLD |
|
DYN
Dyne TherapeuticsΒ Inc |
STRONG BUY
14 analysts |
$38 | 62 BUY |
|
DNTH
Dianthus Therapeutics In⦠|
STRONG BUY
12 analysts |
$128 | 57 HOLD |
Advanced BHVN Option Strategies
Professional options setups generated by AI based on today's BHVN price and gamma walls.